Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors

NCT00003476 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Childhood Brain Tumor

Interventions

DRUG: Antineoplaston therapy (Atengenal + Astugenal)

Sponsor

Burzynski Research Institute